(Q42344436)

27 October 2017

0 references

Dendritic cell-derived exosomes for cancer immunotherapy: hope and challenges (English)

1 reference

27 October 2017

1 reference

1 reference

Hong Tian

1

1 reference

PMC publication ID

5451628

27 October 2017

Wei Li

series ordinal

2

1 reference

27 October 2017

1 May 2017

1 reference

Annals of Translational Medicine

27 October 2017

1 reference

27 October 2017

5

1 reference

27 October 2017

10

1 reference

27 October 2017

221

1 reference

Neoantigen-based cancer immunotherapy

27 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5451628

Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5451628

Dendritic Cell-Based Immunotherapy: State of the Art and Beyond.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5451628

Dendritic cell-derived exosomes for cancer therapy

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5451628

The future of immune checkpoint therapy

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5451628

DCVax®-L--developed by Northwest Biotherapeutics

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5451628

Dendritic cell-derived exosomes need to activate both T and B cells to induce antitumor immunity

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5451628

Cancer immunotherapy via dendritic cells

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5451628

Prospects for exosomes in immunotherapy of cancer

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5451628

Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5451628

A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5451628

Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5451628

B lymphocytes secrete antigen-presenting vesicles

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5451628

Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes)

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5451628

Updated Technology to Produce Highly Immunogenic Dendritic Cell-derived Exosomes of Clinical Grade

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5451628

Long Overall Survival After Dendritic Cell Vaccination in Metastatic Uveal Melanoma Patients

1 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28603736

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28603736

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28603736

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.21037/ATM.2017.02.23

1 reference

27 October 2017

1 reference

PMC publication ID

5451628

27 October 2017

PubMed publication ID

28603736

1 reference

PMC publication ID

5451628